An overview of the biological disease modifying drugs available for arthritic conditions in South Africa
The past decade has seen a major change in the treatment options and strategies for rheumatoid arthritis (RA) and the other immune-mediated arthritic diseases. The disease modifying antirheumatic drugs (DMARDs) are now used in early stages of the disease in order to preserve joint architecture. Ther...
Saved in:
| Main Authors: | Leonie Harmse, Helmuth Reuter |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
AOSIS
2016-12-01
|
| Series: | South African Family Practice |
| Subjects: | |
| Online Access: | https://safpj.co.za/index.php/safpj/article/view/4595 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
DEVELOPMENTS OF RUSSIAN ORIGINAL BIOLOGICAL AGENTS FOR THE TREATMENT OF IMMUNOINFLAMMATORY RHEUMATIC DISEASES
by: E. L. Nasonov, et al.
Published: (2017-04-01) -
TUMOR NECROSIS FACTOR-α MEMBRANE-BOUND AND SOLUBLE RECEPTORS IN NORM AND IN RHEUMATOID ARTHRITIS
by: A. A. Alshevskaya, et al.
Published: (2012-05-01) -
The study of pharmacodynamics of a medicine based on humanized monoclonal antibodies against IL-17 in rabbit model of antigen-induced arthritis
by: A. A. Nedorubov, et al.
Published: (2018-02-01) -
Drug-Induced Sarcoid-like Reactions Associated to Targeted Therapies and Biologic Agents
by: Federica Andolfi, et al.
Published: (2025-06-01) -
Estimation of TNF- α and some immunological parameters in patient with systemic lupus erythematosus
by: sarah AL-abdullah, et al.
Published: (2024-12-01)